CoChat

Is Cell Death a Critical End Point for Anticancer Therapies or Is Cytostasis Sufficient?

Rixe, Olivier, Fojo, Tito · 2007 · Clinical Cancer Research

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Since the discovery of conventional chemotherapy and the development of new target-based agents, the importance of cytostasis in anticancer activity has been debated. This review examines the relative importance of both cytostasis and cytotoxicity based on both preclinical data and clinical reports. Several limitations of our basic and clinical methods to evaluate cytostasis and cytotoxicity will be highlighted. Molecular mechanisms of cytostasis will be analyzed, including interference with the cell cycle as well as putative links with necrosis and autophagy. Finally, we will cite evidence that most older and newer compounds are both cytostatic and cytotoxic. The relative role of cytostasis and cytotoxicity on future drug screening and clinical development will be explored.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-07-2141

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 60 references

Cited by

See all 167

Metadata

Authors
Rixe, O., & Fojo, T.
Affiliations
  • Université Pierre-et-Marie-Curie (FR)
  • National Cancer Institute (US)
Venue
Clinical Cancer Research
Published
2007-12-15
Volume
13
Issue
24
Pages
7280-7287
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2172156898
Cited by
147
References
57
Citations by year
2025: 6 · 2024: 9 · 2023: 4 · 2022: 15 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 7 · 2017: 8 · 2016: 11 · 2015: 16 · 2014: 13 · 2013: 9 · 2012: 6
FWCI
0.56
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords
cytostasis, cytotoxicity, cell death, anticancer drug evaluation, cell cycle arrest, necrosis, autophagy, cytotoxic chemotherapy, drug screening
MeSH terms
Animals, Antineoplastic Agents, Clinical Trials as Topic, Humans, Neoplasms, Drug Delivery Systems, Cell Death, Cell Proliferation, Cytostatic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is Cell Death a Critical End Point for Anticancer Therapies or Is Cytostasis Sufficient? https://app.cochat.ai/papers/10.1158/1078-0432.ccr-07-2141
The paper
Rixe, O., & Fojo, T. (2007). Is Cell Death a Critical End Point for Anticancer Therapies or Is Cytostasis Sufficient? Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-07-2141

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.